1. Home
  2. XPON vs BCDA Comparison

XPON vs BCDA Comparison

Compare XPON & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Expion360 Inc.

XPON

Expion360 Inc.

N/A

Current Price

$5.19

Market Cap

3.3M

Sector

Technology

ML Signal

N/A

Logo BioCardia Inc.

BCDA

BioCardia Inc.

HOLD

Current Price

$1.10

Market Cap

14.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XPON
BCDA
Founded
2016
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
14.1M
IPO Year
2022
2009

Fundamental Metrics

Financial Performance
Metric
XPON
BCDA
Price
$5.19
$1.10
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$25.00
AVG Volume (30 Days)
5.2M
162.2K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
94.63
N/A
EPS
N/A
N/A
Revenue
$9,651,870.00
$479,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
71.59
N/A
52 Week Low
$0.26
$0.75
52 Week High
$11.79
$2.27

Technical Indicators

Market Signals
Indicator
XPON
BCDA
Relative Strength Index (RSI) 51.50 56.90
Support Level $0.53 $0.78
Resistance Level $11.79 $1.26
Average True Range (ATR) 1.42 0.06
MACD -0.24 -0.00
Stochastic Oscillator 22.13 50.73

Price Performance

Historical Comparison
XPON
BCDA

About XPON Expion360 Inc.

Expion360 Inc focuses on the design, assembly, manufacturing, and sale of lithium iron phosphate (LiFePO4) batteries and related accessories for RV, marine, and industrial applications. Its high-performance battery solutions are designed for high energy density and a compact footprint, supported by engineering and intellectual property to enhance safety, quality, and performance. The company also engages in product design, development, and collaboration to strengthen customer relationships. It serves dealers, wholesalers, private-label customers, and OEMs, who distribute its products to end consumers. Its segment is Energy Storage (ES), providing lithium-based energy solutions backed by durable materials, optimized internal structures, and responsive customer service.

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

Share on Social Networks: